Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |